Companies hunting for new ways to tackle cancer to Alzheimer's raised $6.3 billion going public in 2018 - here are the 10 biggest deals of the year

• Biotech initial public offerings hit a record high in 2018 with big deals like Moderna's $604 million offering in December and Allogene's $324 million offering in October.

• In total, there have been 58 biotech IPOs in 2018, raising a total of $6.3 billion, according to Renaissance Capital.
• Here are the 10 IPOs that made the biggest splash and broke records in 2018.

It's been a massive year for biotech companies to go public.

In the past year, companies have raised more than $6.3 billion in 58 deals, according to Renaissance Capital. It's the highest number of offerings since 2014, when there were 71 biotech IPOs that raised a combined $5.2 billion.

Here are the 10 biotech IPOs that made the biggest splash and broke records in 2018.

Charlotte Hu contributed to an earlier version of this post.